))
High Stakes, High Concentrations: Inside Biologics Innovation (Part 1)
Manage episode 513359184 series 3428201
Kymanox에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 Kymanox 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.
In today’s pharma landscape, patient convenience and drug delivery innovation go hand in hand. But how do you deliver life-saving biologics at higher concentrations without sacrificing safety, stability, or patient comfort?
In this live-recorded episode of Life Science Solutions, host Chris Adkins sits down with Ryan Doxey, Vice President of Technical Services at Kymanox, for part one of their conversation together. Ryan unpacks the opportunities and challenges of hyper-concentrated formulations, from why patients stand to benefit to how technical hurdles like viscosity, stability, and scale-up shape the path forward.
Chris and Ryan dig into what makes high-concentration biologics both technically challenging and clinically promising.
Topics Include:
- Why high-concentration biologics matter for patient convenience and compliance
- The science of formulation: balancing potency, viscosity, and stability
- Scale-up and manufacturing barriers innovators must solve
- Lifecycle management and the competitive edge of delivery innovation
This is part one of a two-part conversation with Ryan Doxey, offering an inside look at how advanced biologics are being reimagined for the patients who need them most.
📍 Recorded live during the Podcast Marathon at Walk West studio in Raleigh North Carolina.
#Biologics #DrugDelivery #PharmaInnovation #CMC #LifeSciences
38 에피소드
공유
